Isolation of inhibin like peptides from human placenta by Bandivdekar, A. H. et al.
J. Biosci., Vol. 7, Number 2, March 1985, pp. 175–190. © Printed in India. 
 
 
 
 
Isolation of inhibin like peptides from human placenta
 
 
A. H. BANDIVDEKAR, S. B. MOODBIDRI and A. R. SHETH
 
Institute for Research in Reproduction, Parel, Bombay 400 012, India
 
MS received 15 January 1985
 
Abstract. Two moieties of inhibin could be obtained by chromatography of partially purified
preparations of inhibin from human placenta on Sephadex G-100, G-25 and ion exchange
chromatography on diethylaminoethyl Sephadex A-50. The higher molecular weight moiety
(14,000) designated as HPI-H appears to be similar to inhibin from human seminal plasma.
While the lower molecular weight moiety (1500) designated as HPI-L appears to be similar to
that of sheep testicular inhibin.
The preparations from both human term placenta and human seminal plasma inhibited the
binding of [125 I] human follicle stimulating hormone to rat testicular receptors. This effect of
inhibins could be neutralized by antisera raised against corresponding polypeptide. Further
these antibodies could neutralize endogenous inhibin resulting in 2 to 3 fold increase in serum
follicle stimulating harmone levels, which could then be reversed by exogenous administration
of the isolated inhibin preparations.
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Introduction 
 
The placenta, which is known to secrete a number of peptides has also been shown to be
a source of inhibin-like peptide (Bandivdekar et al., 1981; Hochberg et al., 1981; Apte
and Sheth, 1982). The present report deals with the purification and characterization of
inhibin-like peptides from full term human placenta.
 
Materials and methods 
 
Human placentae from full term normal deliveries were obtained from maternity
hospitals. Fresh placentae were collected and trasported to the laboratory in ice and
processed immediately.
The foetal part of the placenta was separated as far as possible from the maternal part
and was homogenized in 0·01 Μ sodium phosphate buffer pH 7·4 in a Braun blender to
obtain a 40 % (w/v) homogenate. The homogenate was then centrifuged for 60 min at
25,000 g, using a Type-19 rotor in a Spinco L2-65 Β centrifuge.
 
 
 
Abbreviations used: HPI-H, Human placental inhibin–high molecular weight; HPI-L, human placental
inhibin–low molecular weight; FSH, follicle stimulating hormone; LH, lutinizing hormone; DEAE,
diethylaminoethyl; PAGE, Polyacrylamide gel electrophoresis; Con-Α, concanavalin A; NRS, normal rabbit
serum; RIA, radioimmunoassay; HSPI, human seminal plasma inhibin; hFSH, human FSH.
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Bioassay for detection of inhibin activity
 
The fractions obtained at each stage of purification were assayed for inhibin activity in
adult intact male rats. Adult male rats of the Holtzman strain, weighing between
200–250 g and 90 days of age were injected intramuscularly once daily with 1 ml saline
or the test material, for 3 days. Four h after the last injection, the animals were bled and
sera collected. The levels of follicle stimulating hormone (FSH) and lutinizing
hormone (LH) in these sera were determined by radioimmunoassay using NIAMDD
systems and were expressed in terms of NIAMDD-Rat-FSH-RP-1 and NIAMDD-
Rat-LH-RP-1, respectively. The serum FSH levels obtained from groups of animals
treated with test material were compared with those from the saline treated group. Any
significant suppression of FSH levels were taken as an index of inhibin activity. All
Statistical evaluations were performed using Student's ‘t’ test. 
 
Chromatography on Sephadex G-100
 
The 25,000 g supernatant (containing a maximum amount of about 1 g protein) was
charged on to Sephadex G-100 column (5 × 100 cm) pre-equilibrated with 0·01 Μ
sodium phosphate buffer, pH 7·4. The column was then eluted with the same buffer at
the rate of 40 ml/h and 10 ml fractions collected. The different fractions were pooled,
and designated on the basis of the order of their elution viz. HPI-G-100-1; HPI-G-100-
2 and HPI-G-100-3. The fractions with inhibin activity were concentrated by
ultrafiltration or lyophilization and subjected to further chromatography.
The fraction HPI-G-100-2 was rechromatographed on Sephadex G-100 column
(3 × 150 cm). The fraction exhibiting inhibin activity designated as HPI-G-G-2 was
further subjected to ion exchange chromatography. 
 
Chromatography on Sephadex G-25
 
The fraction HPI-G-100-3 was further subjected to gel filtration on Sephadex G-25
column (2·5 × 38 cm). Five fractions were obtained. The fraction eluting immediately
after the void volume was found to be active and was designated as HPI-L (human
placental inhibin – low molecular weight moiety). 
 
Ion exchange chromatography on DEAE Sephadex A-50 
 
The fraction HPI-G-G-2 was then charged on diethylaminoethyl (DEAE)-Sephadex
A-50 column (2·5 × 20 cm). Both the column and the fraction were equilibrated with
0·05 Μ Tris-HCl buffer, pH 8·0. The column charged with the fraction was then eluted
initially with the same buffer and then stepwise with 0·01, 0·05, 0·1, 0·5 and 1·0 Μ
sodium chloride in 0·05 Μ Tris-HCl buffer, pH 8·0. The fractions were collected at the
rate of 20 ml/h. The fraction with inhibin like activity was further rechromatographed
on DEAE Sephadex A-50, using 0·05 Μ Tris HCl buffer, pH 8·0 for equilibration and
initial elution and 0·1, 0·2 and 0·5 Μ NaCl in 0·05 Μ Tris-HCl buffer, pH 8·0 for
stepwise elution of the column. The fractions were pooled and dialysed extensively
against distilled water and lyophilized. The active fraction was designated as HPI-H
(human placental inhibin–high molecular weight). 
Inhibin from human seminal plasma was purified as described earlier (Sheth et al.
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1984). Acetone dry powder of human seminal plasma was chromatographed on
Sephadex G-100 using 0·05 Μ sodium acetate buffer pH 4·0 and then on DEAE-
Sephadex A-50. Purity of the inhibin preparation was checked on reverse phase high
performance liquid chromatography (Sheth et al., 1984).
The protein content of the fractions obtained at different stages of purification were
determined by the method of Lowry et al. (1951) using bovine serum albumin as
Standard. 
 
Polyacrylamide gel electrophoresis 
 
Homogeneity of the high molecular weight active fractions were tested on poly-
acrylamide disc gel electrophoresis (PAGE) at pH 8·3 using 7·5 % running gel (Davis
1964). 
 
Chromatography on Concanavalin A Sepharose 4B 
 
About 20 mg of purified HPI-H was applied on Concanavalin A (Con-Α) Sepharose-
4B column (3 × 30 cms), pre-equilibrated with 0·1 Μ sodium acetate buffer, pH 6·0
containing 1 Μ NaCl, 1 mM each of MnCl2 and CaCl2. The column was then washed
with the same buffer until the effluent showed no measurable absorbance at 280 nm.
Glycoproteins if present bind strongly to Con-A Sepharose-4B and can be recovered by
elution of the column with 2 % α-methyl-D mannoside in the same buffer.
 
Preparation of antibodies to human placental inhibin
(high molecular weight)–(As-HPI-H)
 
Antibodies to the high molecular wieght inhibin preparation obtained from human
placenta (HPI-H) were raised in rabbits by active immunization. 100 µg of purified
HPI-H was dissolved in 1 ml saline and emulsified with an equal volume of Freund’s 
complete adjuvant and administered intra-dermally at multiple sites. A second injection
was given 6 weeks later. Four weeks after the second injection, the animals were bled
and the sera harvested and stored frozen until tested and was designated as As-HPI-H.
Antibodies to human seminal plasma inhibin (As-HSPI) were raised in our
laboratory as described by Vaze et al., (1979). 
 
In-vivo neutralization of endogenous inhibin in immature rats with As-HPI-H 
 
Ten day old male rats of Holtzman strain were injected with 50 and 100 µl of As-HPI-H
or with normal rabbit serum (NRS) (as a control) on days 10, 11 and 12 of age. The
animals were bled 4 h after the last injection. The serum FSH levels were measured by
radioimmunoassay (RIA).
The in vivo effects observed in the above experiments were again confirmed in intact
adult male rats for specific neutralization. Three month old intact male rats were injected
for 3 days with a total dose of either 10 and 20 µg of HPI-H, or 250 and 500 µg of HPI-
L, or 50 and 100 µg of human seminal plasma inhibin (HSPI). Another group of
animals were administered 50 and 100 µ1 of either As-HPI-H or As-HSPI. Several
combinations of HPI-L, HPI-H and HSPI with 100 µl of As-HPI-H and As-HSPI were
also administered. In the two control groups, saline and NRS were injected as controls.
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Four h after the last injection, animals were bled by cardiac puncture and their sera were
harvested and assessed for FSH levels by RIA.
 
In vitro effect of inhibin and its antiserum
 
In vitro FSH receptor binding inhibition by inhibin: Receptors were prepared from
testes of 90 day old rats of Holtzman strain and was equivalent to fraction R-l of
Reichert and Abou-Issa (1977). Five hundred µl of this receptor preparation was
incubated with 5 ng of [125I]-human FSH (hFSH), in the presence of appropriate
amounts of HPI-H, HPI-L and HSPI, dissolved in 400 µl of 0·05 Μ Tris-HCl buffer
pH 7·5 containing 0·1 % bovine serum albumin, 0·1 Μ sucrose and 5 mM MgCl2 (assay
buffer). The tubes containing the above Tris-HCl buffer instead of test material served
as control while, non specific binding was determined by the addition of a 1000 fold
excess cold hFSH (i.e. 5 µg). The tubes were then incubated in a metabolic shaker at
37°C for 3 h and then resuspended in 2 ml chilled buffer and centrifuged at 1500 g for
20 min. The supernatants were decanted and the tubes were counted in a gamma ray
spectrometer.
 
In vitro neutralization of FSH-receptor binding inhibitor activity by antibodies to
inhibin: The antibodies to HPI-H and HSPI in various combinations were pre-
incubated at 4°C for 24 h with HPI-H, HPI-L and HSPI. HPI-H, HPI-L and HSPI
were also preincubated with 50 and 100 µl of NRS and assay buffer. After a 24 h
incubation in cold and then centrifugation to remove the precipitated antigen-antibody
complex, the supernatant was checked for FSH-RBI activity as described above.
 
 
Results
 
Flow-chart 1 shows the schematic representation of purification of inhibin from
human placenta. The fractions obtained following gel filtration are shown in figure 1.
Fractions HPI-G-100-2 and HPI-G-100-3 significantly suppressed serum FSH levels in
intact adult male rats, while fraction HPI-G-100-1 did not do so (table 1).
The most retarded fraction i.e. HPI-G-100-3 resolved into 5 fractions (figure 2)
following further chromatography on Sephadex G-25 column. The fraction eluting
immediately after the void volume, exhibited inhibin-like activity as assessed by
bioassay in intact adult male rats, while the other fractions were devoid of any inhibin-
like activity (table 2). This active fraction with inhibin like activity was designated as
HPI-L.
The HPI-G-100-2 fraction following rechromatography on Sephadex G-100 column
(3 × 150 cm) resolved into two fractions (figure 3). Inhibin-like activity was observed in
the fraction which eluted later, when tested in intact adult male rats (table 3). This
active fraction was designated as HPI-G-G-2.
Four fractions were obtained when the fraction HPI-G-G-2 was subjected to ion
exchange chromatography on DEAE-Sephadex A-50 column and eluted stepwise with
0·01 to 1 Μ NaCl in 0·05 Μ Tris-HCl pH 8·0 (all the fractions were obtained when the
column was eluted with 0·1 Μ NaCl in 0·05 Μ Tris-HCl buffer, pH 8·0, figure 4). The
fractions were designated as HPI-D-1, HPI-D-2, HPI-D-3 and HPI-D-4. Bioassay of
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Flow-chart 1. Schematic representation of purification of inhibin from human term
placenta. 
 
 
Figure 1. Elution profile of human placental homogenate on Sephadex G-100 column
(5 × 100 cm). The elution buffer was 0·01 Μ sodium phosphate buffer, pH 7·4, the flow rate
was 40 ml/h and the fraction volume was 10 ml.
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Table 1. Inhibin activity of the fractions obtained by chromatography of placental homogenate on
Sephadex G-100 column (5 × 100 cm)
 
 
* P <  0·01. ** P < 0·001.
 
 
 
 
Figure 2. Elution profile of rechromatography of fraction HPI-G-100-3 on Sephadex G-25
column (2·5 × 40 cm). The elution buffer  was 0·01 Μ sodium phosphate buffer, pH 7·4, the
flow rate was 18 ml/h and the fraction volume was 3 ml.
 
 
these fractions in intact adult male rats showed the existence of inhibin activity in
fraction HPI-D-4 (table 4). 
Rechromatography of HPI-D-4 on DEAE-Sephadex A-50 when eluted with 0·1 Μ
NaCl in 0·05 Μ Tris-HCl buffer, pH 8·0 further resolved into 3 fractions. These
fractions were designated on the basis of their emergence as HPI-D-D-1, HPI-D-D-2
and HPI-D-D-3 (figure 5). HPI-D-D-3 could significantly suppress FSH levels in intact
adult male rats while the other fractions were devoid of FSH suppressing activity
(table 5). 
The fraction HPI-D-D-3 was found to be homogeneous on Polyacrylamide gel
electrophoresis at pH 8·3 (figure 6) and this fraction was designated as HPI-H.
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Table 2. Inhibin activity of the fractions obtained by rechromatography of HPI-G-100-3 on Sephadex G-
25 column (2·5 × 40 cm).
 
*  P < 0·01. 
 
 
 
 
 
 
 
 
Figure 3. Elution profile of rechromatography of fraction HPI-G-100-2 on Sephadex G-
100 column (3 × 150 cm). The elution buffer was 0·01 Μ sodium phosphate buffer, pH 7·4, the
flow rate was 20 ml/h and the fraction volume was 5 ml.
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Table 3.  Inhibin activity of the fractions obtained by rechromatography of HPI-G-100-2 on Sephadex G-
100 column (3·0 × 150 cm).
 
* P < 0·01  ** P < 0·001. 
 
 
 
 
 
 
Figure 4. Elution profile of ion-exchange chromatography of fraction HPI-G-G-2 on
DEAE Sephadex A-50 column. Fractions were eluted with 0·1 Μ NaCl in 0·05 Μ Tris-HCl
pH 8·0. 
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Table 4. Inhibin activity of the fractions obtained by ion exchange chromatography of HPI-G-G-2 on
DEAE Sephadex A-50 column. 
 
* P < 0·01. ** P < 0·001. 
 
 
 
Figure 5. Elution profile of ion exchange chromatography of fraction HPI-D-4 on DEAE
Sephadex A-50 column. Fractions were eluted with 0·1 Μ NaCl in 0·05 Μ Tris-HCl pH 8·0.
 
The purified HPI-H when charged on Con-Α Sepharose 4B, was eluted in the
unadsorbed fraction only, suggesting that it is not glycoprotein.
 
In vivo effect of inhibin and its antiserum
 
Immature male rats: As-HPI-H when injected in 10 day old male rats on day 10, 11 and
12 of age caused 2 to 3 fold increase in serum FSH levels at a total dose of 50 and 100 µl
respectively (table 6).
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Table 5. Inhibin activity of the fractions obtained by ion exchange chromatography of HPI-D-4 on 
DEAE-Sephadex A-50. 
  
* P < 0·01.   ** P < 0·001. 
 
 
 
 
 
 
Figure 6. Electrophoretic pattern of HPI-H on Polyacrylamide gel electrophoresis at
pH 8·3 using 7·5 % running gel. 
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Table 6. In vivo effect of As-HPI-H in 10 day-old intact male
rats on circulating levels of FSH. 
 
* P < 0·001. 
 
 
 
Adult male rats: While confirming the specific in vivo neutralization of endogenous
inhibin, As-HPI-H and As-HSPI were injected and in another group HPI-H, HPI-L
and HSPI were injected. In yet another group, several combinations of As-HPI-H, As-
HPSI and HPI-H, HPI-L, HSPI were injected. NRS and saline were injected in two
control groups. Antiserum to HPI-H and HSPI caused about 2 to 3 fold increase in
serum FSH at the dose of 50 and 100 µl respectively, while HPI-H, HPI-L and HSPI
caused about 20 to 70 % inhibition in serum FSH levels.
When simultaneous administration of 100 µl of As-HPI-H/As-HSPI alongwith
HPI-H, HPI-L or HSPI resulted in a decrease in FSH levels (figure 7) than those
observed with antiserum alone, suggesting thereby the specific in vivo neutralization of
inhibin. 
 
In vitro effect of inhibin and its antiserum
 
FSH binding inhibition to its receptor: Five to six per cent specific binding of [125I]-
hFSH to rat testicular receptor was observed. This specific binding was inhibited in a
dose related manner by HPI-H, HPI-L and HSPI when 25 to 200 µg were added
(table 7).
An increased binding of [125I]-hFSH to rat testicular receptor was observed in the
presence of As-HPI-H and HSPI as compared to when HPI-H and HSPI were
incubated alone (figure 8).
While As-HPI-H and As-HSPI preincubated with HPI-L did not significantly effect
[125I]-hFSH binding to rat testicular receptors. These results suggested that As-HPI-H
and As-HSPI neutralized the in vitro activities of HPI-H and HSPI while HPI-L did not
(figure 8). 
 
Discussion
 
Inhibin, a FSH inhibiting peptide, shown to be of a gonadal as well as extragonadal
origin was isolated from various sources. The existence and partial purification of
inhibin using human term placenta as a source was reported for the first time from our
laboratory (Bandivdekar et al., 1981). The present study describes the purification and
immunobiological characterization of inhibin from human placenta.
Studies on the in vitro synthesis of inhibin by the human placenta established that
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Table 7. In vitro binding inhibition of [125I]-hFSH to rat testicular receptor by HPI-H, HPI-L and HSPI.
 
* P < 0·01.   ** P < 0·001. 
Numbers in parentheses represent the number of observations. 
 
 
 
only the fetal part synthesizes inhibin (Bandivdekar et al., 1984). Hence, for the
purification only fetal part enriched portion of the placenta was used.
The present study reports the isolation of a high molecular weight and a low
molecular weight moiety exhibiting inhibin like activity from the human placenta. The
HPI-H appears to be homogeneous as judged by PAGE. The chromatographic elution
profile of HPI-H and that of HSPI suggests the possible similarity of these two
preparations, while the HPI-L preparation from human placenta exhibited similar
elution profiles as described earlier for inhibin preparations obtained from testes of
sheep, human, rat and chicken (Vijayalakshmi et al., 1980; Bandivdekar et al., 1982).
However, a detailed chemical structure is needed to confirm their identity.
Several different molecular weight proteins ranging from 1500 to 160,000 exhibiting
inhibin-like activity have been reported (Moodbidri et al., 1976; Vijayalakshmi et al.,
1980; Cahoreau et al., 1979; Lugaro et al., 1974; deJong and Sharpe, 1976; Sairam 1981;
Schwartz and Channing, 1977). These differences in molecular weight could be either
due to polymer formation or due to combination of native inhibin and a carrier
substance or a large active protein giving rise to smaller still active fragments. Yet
another possibility is the presence of several active peptides with inhibin-like activity.
But the cause, if any, for this association or dissociation is not yet clear. Whether it is
due to experimental artefacts or due to presence of some intrinsic factor(s) in the
starting material itself which is responsible for the aggregation or breaking up of the
molecule has not been established.
Several workers have suggested that the initial extraction procedures like ethanol
precipitation (Franchimont et al., 1975), amicon ultrafiltration (Davies et al., 1979) and
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Figure 8. In vitro neutralization of HPI-H and HSPI with As HPI-H and As HSPI on the
basis of their binding of [125I]-hFSH to rat testicular receptors.
 
 
ammonium sulphate (Sato and Ishibashi, 1978) results in the aggregation of the
molecules and hence, the reported differences in molecular weight. 
Franchimont et al. (1977) reported that the low molecular weight species is lost when
proteins are precipitated with ethanol as an initial step. This was later confirmed by
Krishnan et al. (1982), who used ethanol in the initial step of purification of inhibin from
human seminal plasma to obtain a high molecular weight inhibin moiety. They further
observed that the alcohol supernatant after concentration using rotary vacuum
evaporation and chromatography on Sephadex G-25 exhibited inhibin activity in the
low molecular weight region. 
These results suggest that the differences in reported molecular weights of inhibin are
not due to aggregation of the molecule during alcohol precipitation or ultrafiltration.
In addition to the descripancies in molecular weight, it is still not clear whether or not
inhibin is a glycoprotein. The low molecular weight form of inhibin obtained from
various tissues or fluids appears to be non-glycoprotein in nature. However, based on
the retention of activity on Con-Α Sepharose columns and subsequent elution by
competiting glycosides, it has been inferred that the inhibin molecule found in bovine
follicular fluid is a glycoprotein (deJong et al., 1980). While the studies from other
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laboratories have shown the absence of carbohydrate moeity in inhibin obtained from 
bull seminal plasma (Chari et al., 1978; Sairam 1981) and human seminal plasma 
(Thakur et al., 1978). In the present study, purified high molecular weight placental 
inhibin was not bound to Con-A Sepharose-4B, suggesting the lack of carbohydrate in 
the placental inhibin. These results suggest but do not prove the absence of 
carbohydrate in the inhibin molecule, as substances may still have some sugar residue 
but simply lack the hexoses in the proper configuration that are usually necessary to be 
bound by Con-Α Sepharose. Much work has been done on its biological actions in 
addition to the physicochemical characterization of inhibin. The results of several 
studies indicate that inhibin could act directly at the hypothalamus (Moodbidri et al., 
1981; Lugaro et al., 1974; LeLannou and Chambon, 1977), pituitary (Baker et al., 1976; 
Rush and Lipner, 1979; Franchimont et al., 1978) and at the gonadal levels (Moodbidri 
et al., 1980; Daume et al., 1979). The present study demonstrates the binding inhibition 
of [125I]-hFSH to rat testicular receptor by HPI-H, HPI-L and HSPI. HPI-L causes
more inhibition than that of HPI-H or HSPI. 
The binding inhibition effect of HPI-H and HSPI could be neutralized by both 
antibodies to HPI-H and HSPI; however, the binding inhibition observed due to HPI- 
L could not be neutralized by either of the antisera. 
Similarly, in in vivo experiments the antibodies to HPI-H as well as HSPI caused dose 
related increase in serum FSH levels which may be due to neutralization of endogenous 
inhibin. This elevated increase in FSH could be suppressed by administration of HPI- 
H and HSPI. 
The results of the present study establishes that the placenta is a source of both the 
high and low molecular weight inhibin like peptide. However, its chemical similarity 
with inhibin from the gonads remains to be established. 
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